tiprankstipranks
pc:adv46

AdvanCell

AdvanCell is a biotechnology startup developing targeted alpha therapies for the treatment of prostate cancer. The company is focused on advancing targeted therapeutic approaches and is expanding its U.S. manufacturing infrastructure to support development and scale.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$315M
Total Amount Raised$315M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$315M
Latest Funding Amount$315M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 17, 2026
Investment
$315.00M

Similar Companies

A snapshot of private companies similar to AdvanCell, helping you discover and navigate related company profiles.

Related News and Analysis